在患有急性不补偿性心力衰竭的败血症患者中,最佳的液体复苏目标
Jie Weng1,2,3, Zhe Xu4, Jiaze Song5
1Department of General Practice, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.
BMC medicine
|October 25, 2024
概括
对于患有急性不补偿性心力衰竭 (ADHF) 的败血症患者,在前3小时内最佳的液体复苏量为10-15毫升/千克. 这种体积范围最大限度地降低了死亡风险,并支持更好的患者结果.
科学领域:
- 关键护理医学 关键护理医学
- 心脏病学 心脏病学
- 败血症管理管理
背景情况:
- 败血症引起的急性减补性心力衰竭 (ADHF) 提出了复杂的流体管理挑战.
- 确定最佳的液体复苏容量对于改善这些脆弱患者的治疗结果至关重要.
研究的目的:
- 为了确定患有急性不补偿性心力衰竭的败血症患者理想的初始液体复苏容量.
- 评估不同液体复苏量与患者死亡率和发病率之间的关联.
主要方法:
- 追溯分析598名有心力衰竭史的败血症患者.
- 用于分析流体体积 (分类为<10, 10-15, 15-20, >20毫升/公斤) 和结果的通用添加剂,物流和考克斯回归模型.
- 主要终点:住院死亡率;次要终点:30天和1年死亡率,侵入性通风,ICU入院.
主要成果:
- 液体体积<10毫升/公斤或>20毫升/公斤显著增加了住院死亡风险.
- 15-20毫升/公斤之间的体积与住院死亡没有显著的关联.
- 过度的液体复苏 (>15毫升/公斤) 增加了气管管道输液的风险.
结论:
- 在ADHF的败血症患者中,在前3小时内进行10-15毫升/千克的初始液体复苏似乎是最佳的.
- 这种体积范围对于心脏功能恶化的患者尤其有益.
- 建议通过大规模随机对照试验进行进一步验证.
相关概念视频
Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Cardiopulmonary Resuscitation IV: Pharmacological Management
1
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1
Heart Failure V: Nursing Interventions
1
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
1
Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3


